Cannabinoid Medication for Adults With OCD

Clinical trial NCT02911324 · COMPLETED

Trial details

NCT number: NCT02911324
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Obsessive-Compulsive Disorder

Start date: 2016-09-01
Primary completion: 2019-01-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.